# Ocular Therapeutix

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/ocular-therapeutix

- Industry: Biotechnology
- Headquarters: Bedford, US
- Website: www.ocutx.com
- Total disclosed funding: $67M
- Latest round: Series D (May 31, 2013)
- Investors on record: 6

## About

Founded in 2006 and based in Massachusetts, US, Ocular Therapeutix Inc. operates as a provider of ophthalmic therapeutic products for ophthalmology and ophthalmic surgery applications. In February 2024, Deep Track Capital, Venrock, TCG Crossover Management, Perceptive Advisors, Great Point Partners, Logos Capital, Surveyor Capital, Acuta Capital Partners, and Opaleye Management agreed to invest approximately USD 325 million in Ocular Therapeutix, Inc., before deducting placement agent fees and other offering expenses. As of 2024, the company is headed by its CEO Pravin U. Dugel. The company bears the ticker symbol NASDAQ: OCUL.

Ocular Therapeutix’s product portfolio includes sustained-release therapies designed to enhance patient compliance and treatment outcomes. Key products include DEXTENZA® and ReSure® Sealant, which are used for managing post-surgical inflammation and sealing incisions, respectively. The company is also developing new therapies using its ELUTYX™ technology, which allows for sustained drug release and has the potential to transform treatments for retinal diseases, glaucoma, and other ophthalmic conditions.

## Funding rounds

- Series D, May 31, 2013, $8.5M — Ascension Ventures, Baxter Ventures
- Series D, Nov 26, 2012, $19M — Versant Ventures, Polaris Partners, SV Health Investors, Ascension Ventures
- Series D, Feb 1, 2011, $14M — Versant Ventures, Polaris Partners, SV Health Investors, Ascension Ventures
- Series C, Jan 11, 2011, $5.1M — Versant Ventures, Polaris Partners
- Series C, Jun 19, 2009, $15M — Versant Ventures, Polaris Partners, SV Health Investors
- Series B, Mar 7, 2008, $6M — Versant Ventures, Pinnacle Ventures, SV Health Investors

## Investors

- Versant Ventures (https://capitalatlas.ai/funds/versant-ventures) — Series B, Series C, Series D
- Pinnacle Ventures (https://capitalatlas.ai/funds/pinnacle-ventures) — Series B
- SV Health Investors (https://capitalatlas.ai/funds/sv-health-investors) — Series B, Series C, Series D
- Polaris Partners (https://capitalatlas.ai/funds/polaris-partners) — Series C, Series D
- Ascension Ventures (https://capitalatlas.ai/funds/ascension-ventures) — Series D
- Baxter Ventures (https://capitalatlas.ai/funds/baxter-ventures) — Series D